BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 31129006)

  • 1. Principles and analytical performance of Papilloplex® HR-HPV, a new commercial CE-IVD molecular diagnostic test for the detection of high-risk HPV genotypes.
    Sakellariou GK; Bilski M; Moreau M; Stofanko M; Liu Y; Boland E; Kapadia D; Harrison M; Fu G
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):46-54. PubMed ID: 31129006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus.
    Bhatia R; Serrano I; Wennington H; Graham C; Cubie H; Boland E; Fu G; Cuschieri K
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
    Bhatia R; Alcaniz Boada E; Bonde JH; Quint WGV; Xu L; Ejegod DM; Cuschieri K; Arbyn M
    J Clin Pathol; 2023 Mar; 76(3):172-176. PubMed ID: 34782423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles and analytical performance of Abbott RealTime High Risk HPV test.
    Huang S; Tang N; Mak WB; Erickson B; Salituro J; Li Y; Krumpe E; Schneider G; Yu H; Robinson J; Abravaya K
    J Clin Virol; 2009 Jul; 45 Suppl 1():S13-7. PubMed ID: 19651363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical performance of a low-cost multiplex polymerase chain reaction human papillomavirus genotyping assay for use in Sub-Saharan Africa.
    Samwel K; Kahesa C; Mwaiselage J; Gonzalez D; West JT; Wood C; Palefsky J; Angeletti PC
    J Med Virol; 2019 Feb; 91(2):308-316. PubMed ID: 30281790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
    Zhang L; Dai Y; Chen J; Hong L; Liu Y; Ke Q; Chen Y; Cai C; Liu X; Chen Z
    J Med Virol; 2018 Jan; 90(1):177-183. PubMed ID: 28851089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
    Ossel J; Litjens RJ; Reijans M; Brink AA; Ummelen M; Ramaekers FC; Hopman AH; Simons G
    J Clin Virol; 2014 Dec; 61(4):540-7. PubMed ID: 25453331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
    Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
    BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing.
    da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z
    J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
    Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
    J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
    Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
    Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):1033-6. PubMed ID: 27048314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2.
    Lee DH; Hwang NR; Lim MC; Yoo CW; Joo J; Kim JY; Park SY; Hwang SH
    Ann Clin Biochem; 2016 Sep; 53(Pt 5):561-7. PubMed ID: 26486441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
    Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
    J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping.
    Lim YK; Choi JH; Park S; Kweon OJ; Park AJ
    J Clin Lab Anal; 2016 Nov; 30(6):1110-1115. PubMed ID: 27121347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.